{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:19:44Z","timestamp":1793841584958,"version":"4.6.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rare diseases predominantly affect children and young people (CYP). Current research involving CYP often fails to adequately represent those from lower socioeconomic backgrounds, contributing to widening health and research inequalities. This concise report proposes a framework to build on successful methods that were able to engage with underrepresented CYP. This was achieved through partnership with social enterprise organisations and utilised connections in the community to provide positive knowledge exchange of local services that may enhance their socioeconomic situation, in turn for engaging on how to improve services or advance research. These insights, together with information from scoping the field, were used to develop a practical framework for inclusive Patient and Public Involvement and Engagement (PPIE) with CYP. This framework has been initially designed to be evaluated in CYP with rare kidney diseases, as an exemplar long term health condition. The model of \u2018PPIE through collaborative empowerment\u2019 leverages existing community trust to reduce barriers to participation, hopefully opening the door to more representative views from children residing in regions of low socioeconomic status. The framework has potential to be adapted to address other inequalities or adaptation for different diseases, hopefully offering a replicable approach to representative research design. The next stages of this research are to implement the framework and formally evaluate its success.<\/jats:p>","DOI":"10.1186\/s41687-026-01056-7","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:20:59Z","timestamp":1774984859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A framework to amplify the voices of underrepresented children and young people in rare disease research"],"prefix":"10.1186","volume":"10","author":[{"given":"L.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hardwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Peipert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-2390","authenticated-orcid":false,"given":"L.","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"crossref","unstructured":"Health TLG (2024) The landscape for rare diseases in 2024. Lancet Glob Health 12(3):e341","DOI":"10.1016\/S2214-109X(24)00056-1"},{"key":"1056_CR2","unstructured":"Department of Health and Social Care (2025 Feb) England rare diseases action plan 2025: main report"},{"key":"1056_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1472-6963-14-89","volume":"14","author":"JP Domecq","year":"2014","unstructured":"Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N et al (2014 Feb 26) Patient engagement in research: a sysytematic review. BMC Health Serv Res 14:89","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"1056_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/biomedicines13020518","volume":"13","author":"S Coimbra","year":"2025","unstructured":"Coimbra S, Santos-Silva A (2025 Feb 19) New advances in chronic kidney disease: biology, diagnosis and therapy. Biomedicines 13(2):518","journal-title":"Biomedicines"},{"issue":"10433","key":"1056_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(23)02843-X","volume":"403","author":"K Wong","year":"2024","unstructured":"Wong K, Pitcher D, Braddon F, Downward L, Steenkamp R, Annear N et al (2024 Mar 30) Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK national registry of rare kidney diseases (RaDaR) cohort. Lancet Lond Engl 403(10433):1279\u20131289","journal-title":"Lancet Lond Engl"},{"issue":"7","key":"1056_CR6","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.ekir.2024.04.062","volume":"9","author":"K Wong","year":"2024","unstructured":"Wong K et al RaDar C (2024 May 9) Description and cross-sectional analyses of 25, 880 adults and children in the UK National Registry of rare kidney diseases cohort. Kidney Int Rep 9(7):2067\u20132083. https:\/\/doi.org\/10.1016\/j.ekir.2024.04.062. PMID: 39081723; PMCID: PMC11284373","journal-title":"Kidney Int Rep"},{"issue":"11","key":"1056_CR7","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1007\/s00431-022-04609-2","volume":"181","author":"JW M\u00e4rz","year":"2022","unstructured":"M\u00e4rz JW (2022 Nov) What does the best interests principle of the convention on the rights of the child mean for paediatric healthcare? Eur J Pediatr 181(11):3805\u20133816","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1056_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.12968\/bjon.2007.16.3.22969","volume":"16","author":"JE John","year":"2007","unstructured":"John JE (2007 Feb 8) The child\u2019s right to participate in research: myth or misconception? Br J Nurs Mark Allen Publ 16(3):157\u2013160","journal-title":"Br J Nurs Mark Allen Publ"},{"issue":"6","key":"1056_CR9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s43441-022-00382-4","volume":"56","author":"J Preston","year":"2022","unstructured":"Preston J, Nafria B, Ohmer A, Gaillard S, Dicks P, West L et al (2022 Nov) Developing a more tailored approach to patient and public involvement with children and families in pediatric clinical research: lessons learned. Ther Innov Regul Sci 56(6):948\u2013963","journal-title":"Ther Innov Regul Sci"},{"issue":"4","key":"1056_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/ije\/30.4.668","volume":"30","author":"N Krieger","year":"2001","unstructured":"Krieger N (2001 Aug) Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiol 30(4):668\u2013677","journal-title":"Int J Epidemiol"},{"key":"1056_CR11","doi-asserted-by":"crossref","unstructured":"Odd DE, Stoianova S, Williams T, Odd D, Edi-Osagie N, McClymont C et al (2024 Feb 12) Race and ethnicity, deprivation, and infant mortality in England, 2019-2022. JAMA Netw Open 7(2):e2355403","DOI":"10.1001\/jamanetworkopen.2023.55403"},{"key":"1056_CR12","doi-asserted-by":"crossref","unstructured":"Panagi L, White SR, Patel S, Bennett S, Shafran R, Ford T (1926) The importance of definitions in the measurement of long-term health conditions in childhood. Variations in prevalence of long-term health conditions in the UK using data from the millennium cohort study, 2004-2015. Int J Methods Psychiatr Res. 2022 Dec; 31(4):e","DOI":"10.1002\/mpr.1926"},{"key":"1056_CR13","doi-asserted-by":"crossref","unstructured":"Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW et al (2010 Feb) Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics 125(2):e349\u2013357","DOI":"10.1542\/peds.2009-0085"},{"issue":"1","key":"1056_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/14777509231196699","volume":"19","author":"J Lindsey","year":"2024","unstructured":"Lindsey J, Doyle M, Wazynska-Finck K (2024 Mar 1) Navigating conflict: the role of mediation in healthcare disputes. Clin Ethics 19(1):26\u201334","journal-title":"Clin Ethics"},{"key":"1056_CR15","doi-asserted-by":"crossref","unstructured":"Hiremath S (2022) Renalism. CMAJ 194(29):E1040\u2013E1040","DOI":"10.1503\/cmaj.146430-l"},{"issue":"2","key":"1056_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/jech-2015-205603","volume":"70","author":"N Shackleton","year":"2016","unstructured":"Shackleton N, Hale D, Viner RM (2016 Feb) Trends and socioeconomic disparities in preadolescent\u2019s health in the UK: evidence from two birth cohorts 32 years apart. J Epidemiol Community Health 70(2):140\u2013146","journal-title":"J Epidemiol Community Health"},{"key":"1056_CR17","doi-asserted-by":"crossref","unstructured":"Guidance on development and operation of Young Persons\u2019 Advisory Groups | Archives of Disease in Childhood [Internet]. [cited 2025 Jun 24]. Available from: https:\/\/adc.bmj.com\/content\/105\/9\/875.2025 Jun 24].","DOI":"10.1136\/archdischild-2019-318517"},{"issue":"2","key":"1056_CR18","first-page":"201","volume":"43","author":"T Thompson","year":"2016","unstructured":"Thompson T, Kreuter M, Boyum S (2016 Apr) Promoting health by addressing basic needs: effect of problem resolution on contacting health referrals. Health Educ Behav Off Publ Soc Public Health Educ 43(2):201\u2013207","journal-title":"Health Educ Behav Off Publ Soc Public Health Educ"},{"key":"1056_CR19","unstructured":"Yates S, Hill K, Blackwell C, Davis A, Padley M, Stone E et al A minimum digital living standard for households with children: overall findings report"},{"issue":"8","key":"1056_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/archdischild-2023-325671","volume":"108","author":"JC Blair","year":"2023","unstructured":"Blair JC, Aitken C, Smith J, Ghatak A, Jones CA, Thursfield R et al (2023 Aug) Socioeconomic barriers preventing children and young people living with long-term health conditions from achieving optimal outcomes. Arch Dis Child 108(8):685\u2013686","journal-title":"Arch Dis Child"},{"key":"1056_CR21","unstructured":"The Lundy model of participation [Internet]. [cited 2025 Jun 24]. Available from: https:\/\/www.corc.uk.net\/the-lundy-model-of-participation\/"},{"issue":"8","key":"1056_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/BPO.0000000000000847","volume":"38","author":"L Phillips","year":"2018","unstructured":"Phillips L, Carsen S, Vasireddi A, Mulpuri K (2018 Sep) Use of patient-reported outcome measures in Pediatric orthopaedic literature. J Pediatr Orthop 38(8):393\u2013397","journal-title":"J Pediatr Orthop"},{"key":"1056_CR23","unstructured":"FDA patient-focused drug development guidance series for enhancing the incorporation of the Patient\u2019s voice in medical product development and regulatory decision making | FDA [Internet]. [2025 Jun 24]. https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical"},{"issue":"4","key":"1056_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s43441-025-00790-2","volume":"59","author":"F Yang","year":"2025","unstructured":"Yang F, Bousnina I, Madej A, Kalamegham R (2025) Has FDA\u2019s drug development tools qualification program improved drug development? Ther Innov Regul Sci 59(4):871\u2013881","journal-title":"Ther Innov Regul Sci"},{"issue":"6","key":"1056_CR25","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41591-022-01781-8","volume":"28","author":"MJ Calvert","year":"2022","unstructured":"Calvert MJ, Cruz Rivera S, Retzer A, Hughes SE, Campbell L, Molony-Oates B et al (2022 Jun) Patient reported outcome assessment must be inclusive and equitable. Nat Med 28(6):1120\u20131124","journal-title":"Nat Med"},{"issue":"3","key":"1056_CR26","first-page":"335","volume":"45","author":"CLC Elorza","year":"2023","unstructured":"Elorza CLC, Santos A, Celeri EHRV (2023) Quality of life, depression and anxiety in children and adolescents with CKD and their primary caregivers. J Bras Nefrol 45(3):335\u2013343","journal-title":"J Bras Nefrol"},{"issue":"1","key":"1056_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/1472-6963-12-431","volume":"12","author":"D Jahagirdar","year":"2012","unstructured":"Jahagirdar D, Kroll T, Ritchie K, Wyke S (2012 Nov 26) Using patient reported outcome measures in health services: a qualitative study on including people with low literacy skills and learning disabilities. BMC Health Serv Res 12(1):431","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"1056_CR28","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1038\/s41591-024-03323-w","volume":"30","author":"OL Aiyegbusi","year":"2024","unstructured":"Aiyegbusi OL, Cruz Rivera S, Kamudoni P, Anderson N, Collis P, Denniston AK et al (2024 Nov) Recommendations to promote equity, diversity and inclusion in decentralized clinical trials. Nat Med 30(11):3075\u20133084","journal-title":"Nat Med"},{"issue":"3","key":"1056_CR29","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/s41390-023-02608-z","volume":"94","author":"E Nash","year":"2023","unstructured":"Nash E, Bickerstaff M, Chetwynd AJ, Hawcutt DB, Oni L (2023) The readability of parent information leaflets in paediatric studies. Pediatr Res 94(3):1166\u20131171","journal-title":"Pediatr Res"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-026-01056-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:16:33Z","timestamp":1781644593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41687-026-01056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1186\/s41687-026-01056-7","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All co-authors take full responsibility for the integrity and accuracy of all aspects of the work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"No patients were directly involved in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate, consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"75"}}